000120555 001__ 120555
000120555 005__ 20240228145452.0
000120555 0247_ $$2doi$$a10.1093/carcin/bgx004
000120555 0247_ $$2pmid$$apmid:28426874
000120555 0247_ $$2ISSN$$a0143-3334
000120555 0247_ $$2ISSN$$a1460-2180
000120555 0247_ $$2altmetric$$aaltmetric:19232363
000120555 037__ $$aDKFZ-2017-00984
000120555 041__ $$aeng
000120555 082__ $$a610
000120555 1001_ $$0P:(DE-He78)dd35af1fb84ec0812fe4bdea97d2f291$$aYang, Rongxi$$b0
000120555 245__ $$aThe association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
000120555 260__ $$aOxford$$bOxford Univ. Press$$c2017
000120555 3367_ $$2DRIVER$$aarticle
000120555 3367_ $$2DataCite$$aOutput Types/Journal article
000120555 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1661255263_31348
000120555 3367_ $$2BibTeX$$aARTICLE
000120555 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120555 3367_ $$00$$2EndNote$$aJournal Article
000120555 520__ $$aBreast cancer (BC) is the leading cancer in women worldwide. Changes in DNA methylation in peripheral blood could be associated with malignant diseases. Making use of screening results by llumina 27K Methylation Assay, we validated demethylation of five CpG sites of S100P gene in blood cell DNA of BC patients by three independent retrospective studies with subjects from different centers (Validation I: 235 familial BC case and 206 controls, odds ratio per -1% methylation > 1.03, and P < 6.00 × 10-8 for all five CpG sites; Validation II: 189 sporadic BC case and 189 controls, odds ratio per -1% methylation > 1.03, P < 8.0 × 10-5 for four CpG sites; Validation III: 156 sporadic BC case and 151 controls, odds ratio per -1% methylation > 1.03, P < 6.0 × 10-4 for four CpG sites). In addition, the blood-based S100P methylation pattern was similar among BC patients with differential clinical characteristics regardless of stage, receptor status and menopause status. The observed BC-associated decreased S100P methylation in blood mainly originates from the leucocytes subpopulations but not B cells. The methylation levels of most S100P CpG sites were inversely correlated with the expression of S100P in leucocytes (P < 1.2 × 10-4) and in tissue (P < 1.1 × 10-4). This study reveals significant association between blood-based decreased S100P methylation and BC, and provides another proof for the application of altered DNA methylation signatures from blood cells as potential markers for the detection of BC, especially for the early stage.
000120555 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000120555 588__ $$aDataset connected to CrossRef, PubMed,
000120555 7001_ $$0P:(DE-He78)f0a01df447f74d4e57b596d985130a15$$aStöcker, Sarah$$b1
000120555 7001_ $$aSchott, Sarah$$b2
000120555 7001_ $$aHeil, Jörg$$b3
000120555 7001_ $$aMarme, Frederik$$b4
000120555 7001_ $$0P:(DE-He78)0a8ada1f5d2ea05fc3af10cd808bfa9a$$aCuk, Katarina$$b5
000120555 7001_ $$0P:(DE-He78)8220e47f6459dc55316cf6b06b0eec3b$$aChen, Bowang$$b6
000120555 7001_ $$aGolatta, Michael$$b7
000120555 7001_ $$aZhou, Yan$$b8
000120555 7001_ $$aSutter, Christian$$b9
000120555 7001_ $$aWappenschmidt, Barbara$$b10
000120555 7001_ $$aSchmutzler, Rita$$b11
000120555 7001_ $$aBugert, Peter$$b12
000120555 7001_ $$aQu, Bin$$b13
000120555 7001_ $$aBartram, Claus R$$b14
000120555 7001_ $$aSohn, Christof$$b15
000120555 7001_ $$0P:(DE-He78)2dc788b30e99b99a3f9b45ca60f3939d$$aSchneeweiss, Andreas$$b16
000120555 7001_ $$0P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aBurwinkel, Barbara$$b17$$eLast author
000120555 773__ $$0PERI:(DE-600)1474206-8$$a10.1093/carcin/bgx004$$gVol. 38, no. 3, p. 312 - 320$$n3$$p312 - 320$$tCarcinogenesis$$v38$$x1460-2180$$y2017
000120555 909CO $$ooai:inrepo02.dkfz.de:120555$$pVDB
000120555 9101_ $$0I:(DE-HGF)0$$6P:(DE-He78)dd35af1fb84ec0812fe4bdea97d2f291$$aExternal Institute$$b0$$kExtern
000120555 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f0a01df447f74d4e57b596d985130a15$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000120555 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)0a8ada1f5d2ea05fc3af10cd808bfa9a$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000120555 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8220e47f6459dc55316cf6b06b0eec3b$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000120555 9101_ $$0I:(DE-HGF)0$$6P:(DE-He78)2dc788b30e99b99a3f9b45ca60f3939d$$aExternal Institute$$b16$$kExtern
000120555 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)15b7fd2bc02d5ef47a2fe2dd0140d2bf$$aDeutsches Krebsforschungszentrum$$b17$$kDKFZ
000120555 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000120555 9141_ $$y2017
000120555 915__ $$0StatID:(DE-HGF)0400$$2StatID$$aAllianz-Lizenz / DFG
000120555 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000120555 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120555 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120555 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120555 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCARCINOGENESIS : 2015
000120555 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000120555 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000120555 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120555 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000120555 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120555 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120555 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120555 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120555 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000120555 9201_ $$0I:(DE-He78)C080-20160331$$kC080$$lMolekulare Epidemiologie$$x0
000120555 9201_ $$0I:(DE-He78)C050-20160331$$kC050$$lMolekular-Genetische Epidemiologie$$x1
000120555 9201_ $$0I:(DE-He78)V964-20160331$$kV964$$lNCT-KliHD$$x2
000120555 980__ $$ajournal
000120555 980__ $$aVDB
000120555 980__ $$aI:(DE-He78)C080-20160331
000120555 980__ $$aI:(DE-He78)C050-20160331
000120555 980__ $$aI:(DE-He78)V964-20160331
000120555 980__ $$aUNRESTRICTED